1960
|
Pyrocarbon starts at the CEA Grenoble (French Atomic Energy Commission),
issued from the joint development with its American partner, General Atomic
Even if it was mainly used for its resistance to temperatures higher than 2000°C, we were far from imagining its medical properties !
|
1968
|
Implantation of the 1st heart valve using Pyrocarbon,
that solves in a revolutionary way thrombogenicity and wear problems.
This mechanical heart valve including Pyrocarbon becomes the universal model and more than 2 millions of patients have now received this surgery.
|
1979
|
Implantation of a series of metacarpo-phalangeal implants using PyC / PyC couple
(Mayo-Clinic, USA)
|
1994
|
Development of the 1st proximal scaphoid pole in Pyrocarbon (APSI)
by Bioprofile's future founders
It demonstrates the exceptional properties of the Pyrocarbon in direct contact with bone and cartilage : no wear and no pain.
|
1999
|
Set up of Bioprofile by 3 founders, coming from a CEA industrial subsidiary
|
2001
|
Bioprofile obtained its Certification ISO 9002 – ISO 13488
|
2002
|
Bioprofile obtained its Certification ISO 9001 – ISO 13485
CE Mark and launching of a range of Pyrocarbon implants:
| |
• STPI (STT arthritis)
|
| |
• PI2 (trapezectomy) |
| |
• RCPI (wrist arthroplasty) |
| |
• MoPyC (radial-head prosthesis) |
|
2004
|
New facilities with installation of Bioprofile's own production reactor |
